How Advocacy can Influence Pricing & Policy Jessica Burry HIV/HCV Pharmacist July 2017
MSF and Access to Medicines Médecins Sans Frontières (MSF), founded in 1971, is an international, independent, medical humanitarian organization that delivers emergency aid to people affected by armed conflict, epidemics, natural disasters and exclusion from healthcare in nearly 70 countries.
MSF and Access to Medicines Life saving essential medicines are either: Unaffordable Unavailable Unsuitable
What’s the Goal? Source: MSF Untangling the Web of Antiretroviral Price Reductions, 15th Edition, July 2012
Today: Still Unaffordable HIV: the price of a third-line regimen is more than 17 times higher than the recommended first-line Source: MSF Untangling the Web of antiretroviral Price Reductions, 18th Edition, July 2016
What are the Challenges? High price of ARVs? Intellectual Property (IP) barriers? Lack of suppliers in the market? Lack of generic competition? Small volumes in the market? Lack of transparancy : $ of R&D? $ of production?
What are the Challenges? High cost of Medicines? Intellectual Property (IP) barriers? Patent Analysis Patent Oppositions Dolutegravir
What are the Challenges? High cost of ARVs? Intellectual Property (IP) barriers? Patent Analysis Patent Oppositions Voluntary Licenses Compulsory Licenses E ‘t Hoen. Private Patents and Public Health: Changing intellectual property rules for access to medicines
What are the Challenges? High cost of ARVs?? Lack of suppliers in the market? Lack of generic competition? Small volumes in the market?
What are the Challenges? High cost of ARVs? Lack of transparancy $ of R&D? $ of production? $ of ARVs in other countries?
Tools & Communication
Communication
Communication
More Info! Waiting Isn’t An Option: HIV & Opportunistic Infection Treatment: Spotlight on Access Gaps: https://msfaccess.org/sites/default/files/HIV_Brief_SpotlightOnAccessGaps_ENG_2017.pdf Waiting Isn’t An Option: https://msfaccess.org/sites/default/files/HIVAIDS_Report_WaitingIsntAnOptionAdvancedHIV_ENG_2017_0.pdf
Merci! Thanks! @jessburry @MSF_Access www.msfaccess.org jessica.burry@geneva.msf.org